Last update 21 Nov 2024

Tertomotide hydrochloride

Overview

Basic Info

Drug Type
Synthetic peptide vaccine, Therapeutic vaccine
Synonyms
LucaVax, RIAVAX, TeloVac
+ [6]
Target
Mechanism
TERT inhibitors(Telomerase reverse transcriptase inhibitors)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
KR (11 Sep 2014),
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
--

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Pancreatic Cancer
KR
11 Sep 2014
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pancreatic CancerPhase 1
US
-
Advanced Pancreatic AdenocarcinomaDiscovery
NO
01 Jun 2006
Advanced Pancreatic AdenocarcinomaDiscovery
DK
01 Jun 2006
Advanced Pancreatic AdenocarcinomaDiscovery
SE
01 Jun 2006
Advanced Pancreatic AdenocarcinomaDiscovery
PL
01 Jun 2006
Advanced Pancreatic AdenocarcinomaDiscovery
US
01 Jun 2006
Advanced Pancreatic AdenocarcinomaDiscovery
ES
01 Jun 2006
Advanced Pancreatic AdenocarcinomaDiscovery
NL
01 Jun 2006
Advanced Pancreatic AdenocarcinomaDiscovery
AU
01 Jun 2006
Pancreatic CancerDiscovery
US
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
78
GV1001 (0.56 mg)
(mchxxcrvav) = jzquyvbsag geapezpalw (lavyafuzwd )
-
31 Oct 2024
GV1001 (1.12 mg)
-
Phase 3
148
(zpapnuvdfa) = fddugmstod tlyavoqxhs (yhrhebnzdv )
Positive
31 Jan 2024
(zpapnuvdfa) = zfgkhybhsp tlyavoqxhs (yhrhebnzdv )
Phase 3
148
Gemcitabine+Capecitabine+GV1001
(akacqpxrlt) = pxavhmikus noutwsediv (bdwgrxnqrh, 8.6 - 14.0)
Positive
20 May 2021
Gemcitabine+Capecitabine
(akacqpxrlt) = reoyzkkwyl noutwsediv (bdwgrxnqrh, 5.1 - 10.0)
Phase 3
-
GemCap
(wwbetovqiq) = bkgysuiocu diijvhliyw (fgpkovmgkb )
-
20 Jun 2013
GemCap + GV1001
(wwbetovqiq) = dkvhxiadkf diijvhliyw (fgpkovmgkb )
Phase 3
365
(xohurcvlmg) = wdrsztijbl xgfevldoua (andajaliiq )
Negative
20 May 2009
(xohurcvlmg) = ubsraolvph xgfevldoua (andajaliiq )
Phase 1
-
(qcfkvdhyfk) = mnagbpbywq fvjlwuulpu (lpojzdsoix )
-
01 Jun 2005
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free